Holds one active US DMF and one valid CEP for hydroxychloroquine, filing since 2022. Its 2025 FDA inspection closed as VAI.
Holds one active US DMF and one valid CEP for hydroxychloroquine, filing since 2022. Its 2025 FDA inspection closed as VAI.
Holds one active US DMF for hydroxychloroquine, filing since 2016. Its 2025 FDA inspection closed as VAI.
Holds one valid CEP for hydroxychloroquine, filing since 2025. Its 2024 FDA inspection closed as NAI.
Holds one valid CEP for hydroxychloroquine, filing since 2025. Its 2025 FDA inspection closed as VAI.
Holds one active US DMF for hydroxychloroquine, filing since 2022. Its 2025 FDA inspection closed as VAI.
Holds 2 active US DMFs for hydroxychloroquine, filing since 2020.
This page filters the worldwide Hydroxychloroquine manufacturer list to companies based in China. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free